T1 Relaxation Time in Lungs of Asymptomatic Smokers

PLoS One. 2016 Mar 9;11(3):e0149760. doi: 10.1371/journal.pone.0149760. eCollection 2016.

Abstract

Purpose: Interest in using T1 as a potential MRI biomarker of chronic obstructive pulmonary disease (COPD) has recently increased. Since tobacco smoking is the major risk factor for development of COPD, the aim for this study was to examine whether tobacco smoking, pack-years (PY), influenced T1 of the lung parenchyma in asymptomatic current smokers.

Materials and methods: Lung T1 measurements from 35 subjects, 23 never smokers and 12 current smokers were retrospectively analyzed from an institutional review board approved study. All 35 subjects underwent pulmonary function test (PFT) measurements and lung T1, with similar T1 measurement protocols. A backward linear model of T1 as a function of FEV1, FVC, weight, height, age and PY was tested.

Results: A significant correlation between lung T1 and PY was found with a negative slope of -3.2 ms/year (95% confidence interval [CI] [-5.8, -0.6], p = 0.02), when adjusted for age and height. Lung T1 shortens with ageing among all subjects, -4.0 ms/year (95%CI [-6.3, -1.7], p = 0.001), and among the never smokers, -3.7 ms/year (95%CI [-6.0, -1.3], p = 0.003).

Conclusions: A correlation between lung T1 and PY when adjusted for both age and height was found, and T1 of the lung shortens with ageing. Accordingly, PY and age can be significant confounding factors when T1 is used as a biomarker in lung MRI studies that must be taken into account to detect underlying patterns of disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aging / physiology
  • Demography
  • Female
  • Humans
  • Lung / pathology
  • Lung / physiopathology*
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Respiratory Function Tests
  • Smoking / adverse effects*
  • Time Factors
  • Young Adult

Grants and funding

This work was supported by AstraZeneca and Allmänna Sjukhusets i Malmö stiftelse för bekämpande av Cancer. The funders provided support in the form of salaries for authors DFA, SSIK, SSY, and MO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.